US Stock MarketDetailed Quotes

RNA Avidity Biosciences

Watchlist
  • 38.480
  • -2.820-6.83%
Close Dec 3 16:00 ET
  • 38.480
  • 0.0000.00%
Post 20:01 ET
4.59BMarket Cap-13361P/E (TTM)

Avidity Biosciences Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-78.35%-65.62M
-30.51%-65M
-43.73%-70.38M
12.63%-119.06M
142.11%16.5M
-15.12%-36.79M
-40.12%-49.81M
-65.57%-48.97M
-43.72%-136.27M
-49.49%-39.19M
Net income from continuing operations
-53.55%-80.4M
-50.54%-70.79M
-31.42%-68.86M
-21.97%-212.22M
-19.76%-60.44M
-20.09%-52.36M
-2.92%-47.03M
-53.04%-52.39M
-47.44%-174M
-30.96%-50.47M
Depreciation and amortization
25.44%710K
29.87%687K
63.94%641K
51.48%2.1M
61.42%615K
52.97%566K
64.29%529K
24.52%391K
117.06%1.39M
83.17%381K
Other non cash items
11.85%821K
12.57%824K
20.35%828K
8.33%2.98M
21.00%824K
6.53%734K
6.09%732K
-0.15%688K
304.86%2.75M
--681K
Change In working capital
-18.99%6.01M
61.91%-4.06M
-128.51%-10.34M
764.99%61.13M
1,756.06%68.9M
109.76%7.41M
-515.44%-10.66M
-64.91%-4.53M
52.21%7.07M
-45.51%3.71M
-Change in prepaid assets
-192.49%-4.82M
-34.36%-9.58M
-269.55%-2.53M
47.94%-3.44M
10.82%-3.01M
274.09%5.21M
-489.99%-7.13M
171.68%1.49M
-163.59%-6.62M
-207.32%-3.37M
-Change in payables and accrued expense
189.56%14.09M
683.93%8.5M
1.47%-3.96M
-76.11%4.91M
-43.20%5.53M
-42.79%4.87M
-170.30%-1.46M
-1,659.30%-4.02M
73.82%20.57M
96.13%9.73M
-Change in other current liabilities
-14.06%-933K
-13.66%-932K
-14.60%-887K
-88.88%-3.33M
-20.53%-916K
-8.92%-818K
-226.69%-820K
---774K
-652.99%-1.76M
---760K
-Change in other working capital
-26.82%-2.34M
-63.99%-2.05M
-142.90%-2.96M
1,330.21%62.99M
3,671.92%67.3M
-49.76%-1.84M
-15.04%-1.25M
-32.21%-1.22M
-15.21%-5.12M
-77.90%-1.88M
Cash from discontinued investing activities
Operating cash flow
-78.35%-65.62M
-30.51%-65M
-43.73%-70.38M
12.63%-119.06M
142.11%16.5M
-15.12%-36.79M
-40.12%-49.81M
-65.57%-48.97M
-43.72%-136.27M
-49.49%-39.19M
Investing cash flow
Cash flow from continuing investing activities
-1,432.49%-482.41M
-696.91%-274.87M
83.27%-32.75M
31.53%-130.07M
757.05%51.04M
-387.95%-31.48M
360.99%46.05M
-11.51%-195.68M
-130.20%-189.96M
90.76%-7.77M
Net PPE purchase and sale
-84.62%-1.7M
14.63%-531K
49.73%-915K
-49.77%-4.23M
-1.53%-863K
-962.62%-923K
52.95%-622K
-140.11%-1.82M
24.52%-2.82M
50.21%-850K
Net investment purchase and sale
-1,473.21%-480.71M
-687.81%-274.34M
83.58%-31.83M
32.75%-125.84M
850.26%51.9M
-382.27%-30.56M
385.94%46.67M
-10.96%-193.86M
-137.55%-187.13M
91.60%-6.92M
Cash from discontinued investing activities
Investing cash flow
-1,432.49%-482.41M
-696.91%-274.87M
83.27%-32.75M
31.53%-130.07M
757.05%51.04M
-387.95%-31.48M
360.99%46.05M
-11.51%-195.68M
-130.20%-189.96M
90.76%-7.77M
Financing cash flow
Cash flow from continuing financing activities
856,060.00%342.46M
1,046.27%446.72M
1,596.12%389.45M
-72.89%93.86M
-86.91%31.89M
-99.90%40K
0.48%38.97M
-4.78%22.96M
96.34%346.17M
1,076.28%243.65M
Net common stock issuance
--465.15M
1,036.43%433.05M
988.37%244.24M
-82.44%60.55M
--0
--0
-0.46%38.11M
-6.90%22.44M
97.38%344.78M
2,577.96%243.08M
Net preferred stock issuance
----
----
----
--31.19M
----
----
----
----
--0
----
Proceeds from stock option exercised by employees
46,662.50%18.71M
-14,848.27%-127.72M
27,823.85%145.2M
52.80%2.13M
21.70%701K
-86.80%40K
72.17%866K
5,100.00%520K
-15.07%1.39M
-50.56%576K
Cash from discontinued financing activities
Financing cash flow
856,060.00%342.46M
1,046.27%446.72M
1,596.12%389.45M
-72.89%93.86M
-86.91%31.89M
-99.90%40K
0.48%38.97M
-4.78%22.96M
96.34%346.17M
1,076.28%243.65M
Net cash flow
Beginning cash position
275.25%578.55M
296.51%471.7M
-45.58%185.38M
6.22%340.65M
-40.30%85.95M
22.99%154.18M
-14.88%118.96M
6.22%340.65M
-0.32%320.7M
-64.91%143.95M
Current changes in cash
-201.28%-205.56M
203.43%106.85M
229.15%286.32M
-878.37%-155.27M
-49.45%99.43M
-466.97%-68.23M
344.44%35.21M
-22.52%-221.69M
2,067.26%19.95M
319.61%196.7M
End cash Position
333.98%372.98M
275.25%578.55M
296.51%471.7M
-45.58%185.38M
-45.58%185.38M
-40.30%85.95M
22.99%154.18M
-14.88%118.96M
6.22%340.65M
6.22%340.65M
Free cash flow
-78.50%-67.32M
-29.95%-65.54M
-40.38%-71.3M
11.36%-123.29M
139.06%15.64M
-18.40%-37.71M
-36.78%-50.43M
-67.44%-50.79M
-41.13%-139.09M
-43.40%-40.04M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -78.35%-65.62M-30.51%-65M-43.73%-70.38M12.63%-119.06M142.11%16.5M-15.12%-36.79M-40.12%-49.81M-65.57%-48.97M-43.72%-136.27M-49.49%-39.19M
Net income from continuing operations -53.55%-80.4M-50.54%-70.79M-31.42%-68.86M-21.97%-212.22M-19.76%-60.44M-20.09%-52.36M-2.92%-47.03M-53.04%-52.39M-47.44%-174M-30.96%-50.47M
Depreciation and amortization 25.44%710K29.87%687K63.94%641K51.48%2.1M61.42%615K52.97%566K64.29%529K24.52%391K117.06%1.39M83.17%381K
Other non cash items 11.85%821K12.57%824K20.35%828K8.33%2.98M21.00%824K6.53%734K6.09%732K-0.15%688K304.86%2.75M--681K
Change In working capital -18.99%6.01M61.91%-4.06M-128.51%-10.34M764.99%61.13M1,756.06%68.9M109.76%7.41M-515.44%-10.66M-64.91%-4.53M52.21%7.07M-45.51%3.71M
-Change in prepaid assets -192.49%-4.82M-34.36%-9.58M-269.55%-2.53M47.94%-3.44M10.82%-3.01M274.09%5.21M-489.99%-7.13M171.68%1.49M-163.59%-6.62M-207.32%-3.37M
-Change in payables and accrued expense 189.56%14.09M683.93%8.5M1.47%-3.96M-76.11%4.91M-43.20%5.53M-42.79%4.87M-170.30%-1.46M-1,659.30%-4.02M73.82%20.57M96.13%9.73M
-Change in other current liabilities -14.06%-933K-13.66%-932K-14.60%-887K-88.88%-3.33M-20.53%-916K-8.92%-818K-226.69%-820K---774K-652.99%-1.76M---760K
-Change in other working capital -26.82%-2.34M-63.99%-2.05M-142.90%-2.96M1,330.21%62.99M3,671.92%67.3M-49.76%-1.84M-15.04%-1.25M-32.21%-1.22M-15.21%-5.12M-77.90%-1.88M
Cash from discontinued investing activities
Operating cash flow -78.35%-65.62M-30.51%-65M-43.73%-70.38M12.63%-119.06M142.11%16.5M-15.12%-36.79M-40.12%-49.81M-65.57%-48.97M-43.72%-136.27M-49.49%-39.19M
Investing cash flow
Cash flow from continuing investing activities -1,432.49%-482.41M-696.91%-274.87M83.27%-32.75M31.53%-130.07M757.05%51.04M-387.95%-31.48M360.99%46.05M-11.51%-195.68M-130.20%-189.96M90.76%-7.77M
Net PPE purchase and sale -84.62%-1.7M14.63%-531K49.73%-915K-49.77%-4.23M-1.53%-863K-962.62%-923K52.95%-622K-140.11%-1.82M24.52%-2.82M50.21%-850K
Net investment purchase and sale -1,473.21%-480.71M-687.81%-274.34M83.58%-31.83M32.75%-125.84M850.26%51.9M-382.27%-30.56M385.94%46.67M-10.96%-193.86M-137.55%-187.13M91.60%-6.92M
Cash from discontinued investing activities
Investing cash flow -1,432.49%-482.41M-696.91%-274.87M83.27%-32.75M31.53%-130.07M757.05%51.04M-387.95%-31.48M360.99%46.05M-11.51%-195.68M-130.20%-189.96M90.76%-7.77M
Financing cash flow
Cash flow from continuing financing activities 856,060.00%342.46M1,046.27%446.72M1,596.12%389.45M-72.89%93.86M-86.91%31.89M-99.90%40K0.48%38.97M-4.78%22.96M96.34%346.17M1,076.28%243.65M
Net common stock issuance --465.15M1,036.43%433.05M988.37%244.24M-82.44%60.55M--0--0-0.46%38.11M-6.90%22.44M97.38%344.78M2,577.96%243.08M
Net preferred stock issuance --------------31.19M------------------0----
Proceeds from stock option exercised by employees 46,662.50%18.71M-14,848.27%-127.72M27,823.85%145.2M52.80%2.13M21.70%701K-86.80%40K72.17%866K5,100.00%520K-15.07%1.39M-50.56%576K
Cash from discontinued financing activities
Financing cash flow 856,060.00%342.46M1,046.27%446.72M1,596.12%389.45M-72.89%93.86M-86.91%31.89M-99.90%40K0.48%38.97M-4.78%22.96M96.34%346.17M1,076.28%243.65M
Net cash flow
Beginning cash position 275.25%578.55M296.51%471.7M-45.58%185.38M6.22%340.65M-40.30%85.95M22.99%154.18M-14.88%118.96M6.22%340.65M-0.32%320.7M-64.91%143.95M
Current changes in cash -201.28%-205.56M203.43%106.85M229.15%286.32M-878.37%-155.27M-49.45%99.43M-466.97%-68.23M344.44%35.21M-22.52%-221.69M2,067.26%19.95M319.61%196.7M
End cash Position 333.98%372.98M275.25%578.55M296.51%471.7M-45.58%185.38M-45.58%185.38M-40.30%85.95M22.99%154.18M-14.88%118.96M6.22%340.65M6.22%340.65M
Free cash flow -78.50%-67.32M-29.95%-65.54M-40.38%-71.3M11.36%-123.29M139.06%15.64M-18.40%-37.71M-36.78%-50.43M-67.44%-50.79M-41.13%-139.09M-43.40%-40.04M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data